NDLI: Synthesis and Antimalarial Activities of Cyclen 4-Aminoquinoline Analogs▿

Content Provider	PubMed Central
Author	Khan, M. O. Faruk Levi, Mark S. Tekwani, Babu L. Khan, Shabana I. Kimura, Eiichi Borne, Ronald F.
Abstract	In an attempt to augment the efficacy of 7-chloro 4-aminoquinoline analogs and also to overcome resistance to antimalarial agents, we synthesized three cyclen (1,4,7,10-tetraazacyclododecane) analogs of chloroquine [a bisquinoline derivative, 7-chloro-4-(1,4,7,10-tetraaza-cyclododec-1-yl)-quinoline HBr, and a 7-chloro-4-(1,4,7,10-tetraaza-cyclododec-1-yl)-quinoline-Zn2+ complex]. The bisquinoline displays the most potent in vitro and in vivo antimalarial activities. It displays 50% inhibitory concentrations (IC50s) of 7.5 nM against the D6 (chloroquine-sensitive) clone of Plasmodium falciparum and 19.2 nM against the W2 (chloroquine-resistant) clone, which are comparable to those of artemisinin (10.6 and 5.0 nM, respectively) and lower than those of chloroquine (10.7 and 87.2 nM, respectively), without any evidence of cytotoxicity to mammalian cells, indicating a high selectivity index (>1,333 against D6 clone and >521 against W2 clone). Potent antimalarial activities of the bisquinoline against chloroquine- and mefloquine-resistant strains of P. falciparum were also confirmed by in vitro [3H]hypoxanthine incorporation assay. The in vivo antimalarial activity of the bisquinoline, as determined in P. berghei-infected mice, is comparable to that of chloroquine (50% effective dose, ≤1.1 mg/kg when given orally); no apparent toxicity has been observed up to the highest dose tested (3 × 30 mg/kg). The bisquinoline inhibits in vitro hemozoin (β-hematin) formation with an IC50 of 1.1 μM, which is about 10-fold more potent than chloroquine (IC50 9.5 μM). Overall, this article describes the discovery of a new class of cyclen 4-aminoquinoline analogs as potent antimalarial drugs.
Related Links	http://dx.doi.org/10.1128/aac.01304-08
Ending Page	1324
Page Count	5
Starting Page	1320
File Format	PDF
ISSN	00664804
e-ISSN	10986596
Journal	Antimicrobial Agents and Chemotherapy
Issue Number	4
Volume Number	53
Language	English
Publisher	American Society for Microbiology (ASM)
Publisher Date	2009-04-01
Access Restriction	Open
Rights Holder	American Society for Microbiology (ASM)
Subject Keyword	Pharmacology (medical) Pharmacology Infectious Diseases Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Infectious Diseases Pharmacology Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Antimalarial Activities and Therapeutic Properties of Febrifugine Analogs

2,N6-Disubstituted Adenosine Analogs with Antitrypanosomal and Antimalarial Activities▿ †

Synthesis and evaluation of 7-substituted 4-aminoquinoline analogs for antimalarial activity

Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine

Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine ▿

4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum.

Design and synthesis of 4 aminoquinoline derivatives as novel antimalarial agents

Antimalarial Activities of the 4-Quinolinemethanols WR-184,806 and WR-226,253†

Antiparasitic Activities and Toxicities of Individual Enantiomers of the 8-Aminoquinoline 8-[(4-Amino-1-Methylbutyl)Amino]-6-Methoxy-4-Methyl-5-[3,4-Dichlorophenoxy]Quinoline Succinate ▿

Synthesis and Antimalarial Activities of Cyclen 4-Aminoquinoline Analogs▿

Similar Documents

Antimalarial Activities and Therapeutic Properties of Febrifugine Analogs

2,N6-Disubstituted Adenosine Analogs with Antitrypanosomal and Antimalarial Activities▿ †

Synthesis and evaluation of 7-substituted 4-aminoquinoline analogs for antimalarial activity

Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine

Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine ▿

4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum.

Design and synthesis of 4 aminoquinoline derivatives as novel antimalarial agents

Antimalarial Activities of the 4-Quinolinemethanols WR-184,806 and WR-226,253†

Antiparasitic Activities and Toxicities of Individual Enantiomers of the 8-Aminoquinoline 8-[(4-Amino-1-Methylbutyl)Amino]-6-Methoxy-4-Methyl-5-[3,4-Dichlorophenoxy]Quinoline Succinate ▿

Synthesis and Antimalarial Activities of Cyclen 4-Aminoquinoline Analogs▿